- •
Despite improvement in median life expectancy and overall health, some children with cystic fibrosis (CF) progress to end-stage lung or liver disease and become candidates for transplant.
- •
Lung and liver transplants have the potential to extend life and improve the quality of life, but require strict adherence to a complex medical regimen.
- •
Chronic lung allograft dysfunction continues to be a major barrier to the success of lung transplants.
- •
Determining the optimal time to move forward with a liver
Transplantation
Section snippets
Key points
Indications
General indications for LTx
Summary
Bilateral LTx and OLT offer survival benefits to patients with end-stage CF lung or liver disease if selected appropriately and timed well.88 It is not an easy path. The medical regimen is complex. The lifelong need to pay close attention to detail is intense and unrelenting. Although quality of life measures are heartening, outcomes as related to morbidity and mortality from complications remain poor and have not changed substantially in the last 20 years for LTx recipients.
It is hoped that,
References (88)
- et al.
American Society of Transplantation executive summary on pediatric lung transplantation
Am J Transplant
(2007) - et al.
A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
J Heart Lung Transplant
(2015) - et al.
Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex
Am J Transplant
(2008) - et al.
Respiratory infections in patients with cystic fibrosis undergoing lung transplantation
Lancet Respir Med
(2014) - et al.
The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric lung and heart-lung transplantation report–2014; focus theme: retransplantation
J Heart Lung Transplant
(2014) - et al.
Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients
J Heart Lung Transplant
(2015) Pediatric lung transplantation
Semin Pediatr Surg
(2006)- et al.
Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial
J Heart Lung Transplant
(2011) - et al.
Herpes simplex and varicella zoster viruses: forgotten but not gone
Am J Transplant
(2007) - et al.
Nonadherence is associated with late rejection in pediatric heart transplant recipients
J Pediatr
(2001)